These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6529535)

  • 1. The first pass metabolism of nifedipine in man.
    Waller DG; Renwick AG; Gruchy BS; George CF
    Br J Clin Pharmacol; 1984 Dec; 18(6):951-4. PubMed ID: 6529535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
    Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
    Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism and pharmacokinetics of nicardipine hydrochloride in man.
    Graham DJ; Dow RJ; Hall DJ; Alexander OF; Mroszczak EJ; Freedman D
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):23S-28S. PubMed ID: 4027149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and metabolism of nifedipine.
    Raemsch KD; Sommer J
    Hypertension; 1983; 5(4 Pt 2):II18-24. PubMed ID: 6862586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of nifedipine: a comparison between two preparations.
    Zylber-Katz E; Koren G; Granit L; Levy M
    Biopharm Drug Dispos; 1984; 5(2):109-15. PubMed ID: 6743779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of oral nifedipine--a population study.
    Renwick AG; Robertson DR; Macklin B; Challenor V; Waller DG; George CF
    Br J Clin Pharmacol; 1988 Jun; 25(6):701-8. PubMed ID: 3203042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.
    Foster TS; Hamann SR; Richards VR; Bryant PJ; Graves DA; McAllister RG
    J Clin Pharmacol; 1983 Apr; 23(4):161-70. PubMed ID: 6863580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the absolute bioavailability of nifedipine.
    Rashid TJ; Martin U; Clarke H; Waller DG; Renwick AG; George CF
    Br J Clin Pharmacol; 1995 Jul; 40(1):51-8. PubMed ID: 8527268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
    Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences in the pharmacokinetics of oral nifedipine.
    Ahsan CH; Renwick AG; Macklin B; Challenor VF; Waller DG; George CF
    Br J Clin Pharmacol; 1991 Apr; 31(4):399-403. PubMed ID: 2049247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.
    Robertson DR; Waller DG; Renwick AG; George CF
    Br J Clin Pharmacol; 1988 Mar; 25(3):297-305. PubMed ID: 3358895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of nicardipine following oral and intravenous administration in man.
    Graham DJ; Dow RJ; Freedman D; Mroszczak E; Ling T
    Postgrad Med J; 1984; 60 Suppl 4():7-10. PubMed ID: 6527979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution and elimination of felodipine in man.
    Edgar B; Hoffmann KJ; Lundborg P; Regårdh CG; Rönn O; Weidolf L
    Drugs; 1985; 29 Suppl 2():9-15. PubMed ID: 3987557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence and metabolism of nitrendipine administered orally to healthy volunteers.
    Kann J; Krol GJ; Raemsch KD; Burkholder DE; Levitt MJ
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S968-73. PubMed ID: 6085386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers.
    Jackson SH; Shah K; Debbas NM; Johnston A; Peverel-Cooper CA; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):389-92. PubMed ID: 3707813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration.
    Kleinbloesem CH; van Harten J; Wilson JP; Danhof M; van Brummelen P; Breimer DD
    Clin Pharmacol Ther; 1986 Jul; 40(1):21-8. PubMed ID: 3720176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.
    Challenor V; Waller DG; Gruchy BS; Renwick AG; George CF; McMurdo ET; McEwen J
    Br J Clin Pharmacol; 1986 Nov; 22(5):565-70. PubMed ID: 3790403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of oral nifedipine in different populations.
    Castañeda-Hernández G; Hoyo-Vadillo C; Palma-Aguirre JA; Flores-Murrieta FJ
    J Clin Pharmacol; 1993 Feb; 33(2):140-5. PubMed ID: 8440762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.